Skip to main content
Book cover

Statistical Applications from Clinical Trials and Personalized Medicine to Finance and Business Analytics

Selected Papers from the 2015 ICSA/Graybill Applied Statistics Symposium, Colorado State University, Fort Collins

  • Conference proceedings
  • © 2016

Overview

  • Focuses on statistical applications from clinical trials, biomarker analysis, and personalized medicine to applications in finance and business analytics
  • A unique selection of papers from broad and multi-disciplinary critical hot topics - from academic, government, and industry perspectives - to appeal to a wide variety of applied research interests
  • All papers feature original, peer-reviewed content
  • Includes supplementary material: sn.pub/extras

Part of the book series: ICSA Book Series in Statistics (ICSABSS)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (25 papers)

  1. Bayesian Methods and Applications

  2. Dose Ranging Studies in Clinical Trials

  3. Innovative Clinical Trial Designs and Analysis

Keywords

About this book

The papers in this volume represent a broad, applied swath of advanced contributions to the 2015 ICSA/Graybill Applied Statistics Symposium of the International Chinese Statistical Association, held at Colorado State University in Fort Collins.  The contributions cover topics that range from statistical applications in business and finance to applications in clinical trials and biomarker analysis.  Each papers was peer-reviewed by at least two referees and also by an editor.  The conference was attended by over 400 participants from academia, industry, and government agencies around the world, including from North America, Asia, and Europe.

Editors and Affiliations

  • Global Statistics, Takeda Pharmaceuticals, Cambridge, USA

    Jianchang Lin

  • Biostatistics, Boehringer Ingelheim Pharmaceuticals, Ridgefield, USA

    Bushi Wang

  • Colorado State University , Fort Collins, USA

    Xiaowen Hu

  • University of Connecticut , Storrs, USA

    Kun Chen

  • Global Statistics, Takeda Pharmaceuticals Global Statistics, Cambridge, USA

    Ray Liu

About the editors

Jianchang Lin, Ph.D., is Principal Statistician at Takeda Pharmaceuticals, with extensive experience in oncology drug clinical development, including leading successful NDA/MAA submissions and worldwide drug approvals.  Dr. Lin’s research interests include Bayesian methodologies, survival analysis and Bayesian adaptive designs, and their application in clinical trials. 

Bushi Wang, Ph.D., is a biostatistician at Boehringer Ingelheim Pharmaceuticals, Inc.  He researches clinical trials across different therapeutic areas and different phases, largely focusing on late stage oncology and cardiovascular trials, supporting approval.  He is co-founder of the Multiple Comparison Procedures Society, a .U.S organization supporting the international MCP conferences. 

Xiaowen Hu, Ph.D., is Assistant Professor in the Department of Statistics, Colorado State University.  Her research interests include spatial analysis, time series analysis, Bayesian analysis, and statistical analysis in business and empirical finance. 

Kun Chen, Ph.D., is Assistant Professor in the Department of Statistics, University of Connecticut.  His research interests include multivariate analysis, dimension reduction, robust statistics, statistical computing and their broad applications in ecology, genetics, public health, and other areas of applied statistics.

Ray Liu, Ph.D., is Head of the Statistical Innovation and Consultation Center at Takeda Pharmaceuticals, Inc.  His research interests include design and analysis of omics studies, integrated analysis, and text mining.

Bibliographic Information

Publish with us